Insulet (PODD) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Insulet Corporation (PODD) insider buying and selling: 6 purchases, 4 sales
60 Form 4 Table I transactions filed with the SEC by Insulet Corporation insiders between 2025-09-09 and 2026-10-05 (15-month history): 6 open-market purchases and 4 sales, plus 50 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a purchase of $1.0M by Mcevoy Ashley on 2026-02-20.
Insulet insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Insulet insiders filed 6 purchases worth $2.9M and 2 sales worth $602k on the open market. The net balance is on the buy side: $2.3M more bought than sold.
The biggest buyer was Mcevoy Ashley (President and CEO): $1.2M in 2 purchases, out of 4 different buyers. The biggest seller was Frederick Wayne A.I. (Director): $543k in 1 sale, out of 2 different sellers.
The largest trade of the period was a purchase of $1.0M on Feb 20, 2026, by Mcevoy Ashley (President and CEO). Form 4 on sec.gov (0001145197-26-000031).
None of the 2 sales carries the 10b5-1 plan flag on the Form 4 (sales scheduled months ahead).
The last three months show 1 purchase and 0 sales, against 2 and 1 in the three before. The latest purchase is from Aug 21, 2026; the latest sale from Jun 3, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Insulet has more sales than 8 of the other 58, ranks 4 of 59 by net dollars bought, and 19 of the 59 have at least one purchase, Insulet included.
The 20 most important trades
The 6 open-market purchases first, then the rest, each type from largest to smallest. The full history is in the tool above, already searched.
See all 60 PODD trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-02-20 | 2026-02-23 | Mcevoy Ashley | President and CEO | $1.0M | P — Open-market purchase3 Form 4 footnotesF1 The price reported represents the weighted average purchase price of the shares acquired. The shares were purchased in multiple transactions at prices ranging from $238.55 to $241.56. Specifically: 2,794 shares were purchased in the range of $238.55 to $238.78, at a weighted average share price of $238.63; 511 shares were purchased in the range of $239.64 to $240.61, at a weighted average share price of $240.06; F2 Footnote continued: 995 shares were purchased in the range of $240.66 to $241.56, at a weighted average share price of $241.01. The Reporting Person hereby undertakes, upon the request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price. F3 Includes 76 shares acquired under the Insulet Corporation Stock Purchase Plan since the date of the Reporting Person's last Section 16 filing. | SEC |
| 2026-02-25 | 2026-02-26 | Minogue Michael R | Director | $500k | P — Open-market purchase Indirect holding, through: By Trust Form 4 footnoteF1 The price reported represents the weighted average purchase price of the shares acquired. The shares were purchased in multiple transactions at prices ranging from $246.04 to $246.42. The Reporting Person hereby undertakes, upon the request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price. | SEC |
| 2026-06-03 | 2026-06-03 | Weatherman Elizabeth H | Director | $497k | P — Open-market purchase2 Form 4 footnotesF1 The price reported represents the weighted average purchase price of the shares acquired. The shares were purchased in multiple transactions at prices ranging from $143.21 to $145. Specifically: 1,607 shares were purchased in the range of $143.21 to $144.13, at a weighted average share price of $143.65; 1,843 shares were purchased in the range of $144.22 to $145, at a weighted average share price of $144.69. F2 Footnote continued: The Reporting Person hereby undertakes, upon the request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price. | SEC |
| 2026-06-03 | 2026-06-04 | Stonesifer Timothy C. | Director | $400k | P — Open-market purchase | SEC |
| 2025-12-05 | 2025-12-08 | Stonesifer Timothy C. | Director | $300k | P — Open-market purchase | SEC |
| 2026-08-21 | 2026-08-24 | Mcevoy Ashley | President and CEO | $162k | P — Open-market purchase2 Form 4 footnotesF1 The price reported represents the weighted average purchase price of the shares acquired. The shares were purchased in multiple transactions at prices ranging from $147.42 to $147.62. The Reporting Person hereby undertakes, upon the request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price. F2 Includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing. | SEC |
| 2025-12-15 | 2025-12-16 | Frederick Wayne A.I. | Director | $543k | S — Open-market sale | SEC |
| 2025-09-08 | 2025-09-09 | Cousin Laetitia | SVP, Reg, Quality & Compliance | $278k | S — Open-market saleForm 4 footnoteF2 The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $348.40 to $348.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. | SEC |
| 2025-09-08 | 2025-09-09 | Singh Prem | SVP, Global Operations | $239k | S — Open-market saleForm 4 footnoteF1 The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $347.35 to $347.51. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. | SEC |
| 2026-06-03 | 2026-06-04 | Borio Luciana | Director | $60k | S — Open-market sale | SEC |
| 2026-02-12 | 2026-02-17 | Benjamin Eric | EVP and COO | $695k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 This transaction represents the withholding of shares upon the vesting of PSUs to cover the associated tax obligations. | SEC |
| 2026-02-12 | 2026-02-17 | Kapples John W. | SVP and General Counsel | $465k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 This transaction represents the withholding of shares upon the vesting of PSUs to cover the associated tax obligations. | SEC |
| 2026-10-01 | 2026-10-05 | Pease Flavia | EVP & CFO | $246k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2 Includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing. | SEC |
| 2026-02-27 | 2026-03-03 | Benjamin Eric | EVP and COO | $225k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. | SEC |
| 2026-05-13 | 2026-05-15 | Mcevoy Ashley | President and CEO | $210k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. | SEC |
| 2026-02-12 | 2026-02-17 | Singh Prem | SVP, Global Operations | $207k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF3 This transaction represents the withholding of shares upon the vesting of PSUs to cover the associated tax obligations. | SEC |
| 2025-09-08 | 2025-09-09 | Cousin Laetitia | SVP, Reg, Quality & Compliance | $192k | M — Option exerciseForm 4 footnoteF1 Includes 93 shares acquired under the Insulet Corporation Stock Purchase Plan since the date of the Reporting Person's last Section 16 filing. | SEC |
| 2026-02-12 | 2026-02-17 | Budden Lauren | Group VP, CAO and Controller | $150k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF3 This transaction represents the withholding of shares upon the vesting of PSUs to cover the associated tax obligations. | SEC |
| 2026-02-27 | 2026-03-03 | Kapples John W. | SVP and General Counsel | $149k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. | SEC |
| 2026-02-12 | 2026-02-17 | Cousin Laetitia | SVP, Reg, Quality & Compliance | $136k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 This transaction represents the withholding of shares upon the vesting of PSUs to cover the associated tax obligations. | SEC |
The period balance: money in, money out
Across the Form 4 filings submitted between Sep 9, 2025 and Oct 5, 2026, Insulet Corporation open-market activity adds up to 6 purchases worth $2.9M and 4 sales worth $1.1M. The net balance is $1.8M on the buy side.
Only codes P and S count, where an insider puts in or takes out their own money. A buying balance like Insulet Corporation's is the less common case in the S&P 500: its insiders are already paid in stock and still put in their own money. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 30 | $102k |
| F | Tax withholding (shares surrendered for taxes) | 19 | $3.0M |
| P | Open-market purchase | 6 | $2.9M |
| S | Open-market sale | 4 | $1.1M |
| M | Option exercise | 1 | $192k |
| Total | Everything filed in the period | 60 | $7.3M |
25 of the 60 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 18 distinct people or entities have filed Insulet Corporation transactions: 4 bought on the open market and 4 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Mcevoy Ashley | President and CEO | 4 | $1.2M (2) | — | 2026-08-24 |
| Stonesifer Timothy C. | Director | 3 | $700k (2) | — | 2026-06-04 |
| Frederick Wayne A.I. | Director | 2 | — | $543k (1) | 2026-05-21 |
| Minogue Michael R | Director | 2 | $500k (1) | — | 2026-05-21 |
| Weatherman Elizabeth H | Director | 2 | $497k (1) | — | 2026-06-03 |
| Cousin Laetitia | SVP, Reg, Quality & Compliance | 8 | — | $278k (1) | 2026-03-03 |
| Singh Prem | SVP, Global Operations | 6 | — | $239k (1) | 2026-03-03 |
| Borio Luciana | Director | 2 | — | $60k (1) | 2026-06-04 |
Shown here are the 8 who moved the most money, out of 18. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Jun 2026: 2 purchases and 1 sale, worth $958k. 10 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 2 | $517k |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 0 | $0 | 0 | $0 |
| Dec 2025 | 1 | $300k | 1 | $543k |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 2 | $1.5M | 0 | $0 |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 0 | $0 |
| May 2026 | 0 | $0 | 0 | $0 |
| Jun 2026 | 2 | $898k | 1 | $60k |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 1 | $162k | 0 | $0 |
| Sep 2026 | 0 | $0 | 0 | $0 |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Insulet Corporation (PODD) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
None of the 4 sales in the table is flagged as scheduled (10b5-1 plan), the kind signed months ahead and executed automatically. Insulet's 6 open-market purchases (code P) are the rare signal: insiders are already paid in stock, so buying more means putting in their own money. The latest filing is from Oct 5, 2026, and a Form 4 arrives up to two business days after the trade.
16 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.